These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 18385149)

  • 61. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Di Micco P; Iannuzzo M; Lecumberri R; Guijarro R; Madridano O; Monreal M;
    Thromb Haemost; 2008 Nov; 100(5):905-11. PubMed ID: 18989537
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical sequelae of thrombus in an inferior vena cava filter.
    Ahmad I; Yeddula K; Wicky S; Kalva SP
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):285-9. PubMed ID: 19688372
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risk factors of nonretrieval of retrievable inferior vena cava filters.
    Siracuse JJ; Al Bazroon A; Gill HL; Meltzer AJ; Schneider DB; Parrack I; Jones DW; Connolly PH
    Ann Vasc Surg; 2015 Feb; 29(2):318-21. PubMed ID: 25308241
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inferior vena cava filters in the management of venous thromboembolism.
    Crowther MA
    Am J Med; 2007 Oct; 120(10 Suppl 2):S13-7. PubMed ID: 17916454
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies.
    Patel A; Anraku M; Darling GE; Shepherd FA; Pierre AF; Waddell TK; Keshavjee S; de Perrot M
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):843-8. PubMed ID: 19660355
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Impact of Cancer on the Clinical Outcome of Patients After Inferior Vena Cava Filter Placement: A Retrospective Cohort Study.
    Narayan A; Hong K; Streiff M; Shinohara R; Frangakis C; Coresh J; Kim HS
    Am J Clin Oncol; 2016 Jun; 39(3):294-301. PubMed ID: 24781342
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
    Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
    Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The use of optional inferior vena cava filters of type Optease in trauma patients--a single type of filter in a single Medical Center.
    Lavan O; Rimon U; Simon D; Khaitovich B; Segal B; Grossman E; Kleinbaum Y; Steinberg DM; Salomon O
    Thromb Res; 2015 May; 135(5):873-6. PubMed ID: 25764911
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Vena cava filters in cancer patients].
    Díaz Couselo FA; Crerar S; Cravero P; Santaera O; Eisele G; Zylberman M
    Medicina (B Aires); 2012; 72(4):287-90. PubMed ID: 22892079
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The management of recurrent VTE in cancer patients receiving therapeutic anticoagulation: the use of dual anticoagulant therapy combined with an IVC filter.
    Pillai AR; Olujohungbe A; Evans MR; Main NJ; Hunt BJ
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):766-9. PubMed ID: 20885300
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Outcomes of patients requiring insertion of an inferior vena cava filter: a retrospective observational study.
    Duffett LD; Gándara E; Cheung A; Bose G; Forster AJ; Wells PS
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):266-71. PubMed ID: 24418944
    [TBL] [Abstract][Full Text] [Related]  

  • 72. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Safety and effectiveness of the celect inferior vena cava filter: preliminary results.
    Sangwaiya MJ; Marentis TC; Walker TG; Stecker M; Wicky ST; Kalva SP
    J Vasc Interv Radiol; 2009 Sep; 20(9):1188-92. PubMed ID: 19631561
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Postoperative recurrence of venous thromboembolism in patients with episodes of preoperative thromboembolism].
    Kuroiwa M; Arai M; Nakahara E; Hoka S
    Masui; 2003 Jul; 52(7):744-9. PubMed ID: 12910975
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Possibilities of using vena cava filters in pregnant women with venous thromboembolism. Case reports.
    Hynek K; Spálová I; Spatenka J; Mates M
    Sb Lek; 2002; 103(4):451-4. PubMed ID: 12688158
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Retrievable inferior vena cava filters are rarely removed.
    Gaspard SF; Gaspard DJ
    Am Surg; 2009 May; 75(5):426-8. PubMed ID: 19445296
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term retrievability of IVC filters: should we abandon permanent devices?
    Berczi V; Bottomley JR; Thomas SM; Taneja S; Gaines PA; Cleveland TJ
    Cardiovasc Intervent Radiol; 2007; 30(5):820-7. PubMed ID: 17763901
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.
    Gussoni G; Frasson S; La Regina M; Di Micco P; Monreal M;
    Thromb Res; 2013 Jan; 131(1):24-30. PubMed ID: 23141849
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants.
    Ghanim AJ; Daskalakis C; Eschelman DJ; Kraft WK
    J Thromb Thrombolysis; 2007 Dec; 24(3):247-54. PubMed ID: 17385008
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.